In-depth looks at practice-changing issues.

  • Long-Term Impact of the ASH Scholar Award Program Tuesday, November 22nd, 2016 | December 2016, Volume 2, Issue 12

    The American Society of Hematology’s (ASH) longest-running award program, the ASH Scholar Award, celebrates more than 30 years of financially supporting fellows and junior faculty as they transition from training programs to careers as independent investigators. Since 1985, ASH has contributed over $41 million in Scholar Award grants and has provided 377 Scholar Awards. This […]

  • Revisiting Maintenance of Certification: Updates from ASH and ABIM Interview with Marc S. Zumberg, MD, and Michael E. Williams, MD, ScM Thursday, September 1st, 2016 | September 2016, Volume 2, Issue 9 | Marc S. Zumberg, MD

    In 2015, the American Board of Internal Medicine (ABIM) issued a statement in response to numerous criticisms from diplomates and specialty societies, including the American Society of Hematology (ASH), about the ABIM Maintenance of Certification (MOC) program. Since then, ABIM, specialty societies, diplomates, and other stakeholders have been involved in multiple discussions regarding the challenges […]

  • If You Build It, They Will Come: Robert Negrin Shares His Vision for Blood Advances Wednesday, April 27th, 2016 | May 2016, Volume 2, Issue 5

    When Robert Negrin, MD, was growing up in Silver Spring, Maryland, if someone had told his parents that their son would one day become a professor of medicine, they “would have just laughed,” Dr. Negrin explained. “I had no interest in science as a kid. I actually wanted to be a baseball player – until […]

  • Bridging the Gap: How ASH Bridge Grant Recipients are Advancing Research Sunday, November 29th, 2015 | December 2015, Volume 1, Issue 12

    Biomedical researchers are operating in a tepid – lukewarm, at best – funding environment. The National Institutes of Health (NIH), a major source of research funding, has experienced across-the-board funding cuts and a steady budget decline, from a peak of $31.2 billion in 2010 to $30.15 billion in 2014. Over the past decade, research grants […]

  • Grassroots Lobbying Efforts Lead to a Win for SCD Patients in Tennessee: An Interview with Michael R. DeBaun, MD, MPH Tuesday, June 16th, 2015 | June 2015, Volume 1, Issue 6

    Sickle cell disease (SCD) is the most common, inherited red blood cell disorder in the United States – affecting 70,000 to 100,000 Americans. Although new approaches in managing SCD have improved diagnosis and supportive care over the past decades, most patients still suffer severe complications from the disorder, and many encounter barriers to accessing high-quality […]

1 of 2
back to top